Total Payments
$3,629
2024 Payments
$438.63
Companies
41
Transactions
186
Medicare Patients
868
Medicare Billing
$55,848
Payment Breakdown by Category
Food & Beverage$3,450 (95.1%)
Education$178.34 (4.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,450 | 180 | 95.1% |
| Education | $178.34 | 6 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $595.47 | 28 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $331.68 | 20 | $0 (2022) |
| CooperSurgical, Inc. | $300.94 | 13 | $0 (2024) |
| Astellas Pharma US Inc | $270.85 | 9 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $254.00 | 16 | $0 (2021) |
| Allergan, Inc. | $180.97 | 14 | $0 (2020) |
| TherapeuticsMD, Inc. | $177.69 | 8 | $0 (2022) |
| PFIZER INC. | $156.11 | 9 | $0 (2024) |
| Duchesnay USA Incorporated | $116.20 | 6 | $0 (2019) |
| Organon Llc | $93.60 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $438.63 | 23 | Astellas Pharma US Inc ($104.84) |
| 2023 | $211.62 | 10 | Astellas Pharma US Inc ($45.94) |
| 2022 | $595.59 | 25 | ABBVIE INC. ($138.52) |
| 2021 | $300.74 | 17 | AbbVie Inc. ($100.45) |
| 2020 | $457.30 | 26 | AbbVie Inc. ($137.15) |
| 2019 | $692.04 | 31 | CooperSurgical, Inc. ($173.92) |
| 2018 | $515.62 | 28 | AbbVie, Inc. ($132.10) |
| 2017 | $417.17 | 26 | Bayer HealthCare Pharmaceuticals Inc. ($96.63) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Biological | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Biological | ||||||
| 10/09/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Diagnostics | ||||||
| 10/01/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | OptumHealth Care Solutions, LLC | VIVIFY HEALTH CARE TEAM PORTAL 001 (Device), EITAN MEDICAL | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Cardiovascular | ||||||
| 09/18/2024 | Ethicon US, LLC | Harmonic (Device), ETHICON, STRATAFIX | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Energy | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Biological | ||||||
| 07/23/2024 | Hologic Sales and Service, LLC | FLUENT FLUID MANAGEMENT SYSTEM (Device), NOVASURE, OMNI HYSTEROSCOPE | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Surgical | ||||||
| 07/18/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Endocrinology | ||||||
| 06/26/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: VACCINES | ||||||
| 05/22/2024 | MILLICENT US INC | — | Education | In-kind items and services | $13.35 | General |
| 05/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Biological | ||||||
| 05/15/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Diagnostics | ||||||
| 04/25/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Endocrinology | ||||||
| 04/25/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $15.59 | General |
| 04/19/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 03/07/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: ETONOGESTREL | ||||||
| 02/21/2024 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 02/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Biological | ||||||
| 02/05/2024 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: OB/GYN | ||||||
| 01/29/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 01/17/2024 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 01/09/2024 | Meditrina | — | Food and Beverage | Cash or cash equivalent | $5.38 | General |
| 08/14/2023 | CooperSurgical, Inc. | PARAGARD T 380A (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Endocrinology | ||||||
| 07/21/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 150 | 166 | $36,360 | $11,724 |
| 2022 | 4 | 174 | 198 | $39,805 | $12,674 |
| 2021 | 6 | 223 | 236 | $42,840 | $14,746 |
| 2020 | 7 | 321 | 343 | $56,804 | $16,704 |
Total Patients
868
Total Services
943
Medicare Billing
$55,848
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 81 | $17,010 | $5,461 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 39 | $12,090 | $3,886 | 32.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 35 | 35 | $3,850 | $1,498 | 38.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,410 | $879.30 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 104 | $21,840 | $6,683 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 37 | $11,470 | $3,482 | 30.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 42 | 42 | $4,620 | $1,816 | 39.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 15 | $1,875 | $691.60 | 36.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 86 | 90 | $18,900 | $6,098 | 32.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 60 | 60 | $6,600 | $2,613 | 39.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 21 | $6,510 | $2,354 | 36.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $4,340 | $1,385 | 31.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 23 | 28 | $3,500 | $1,188 | 33.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 23 | 23 | $2,990 | $1,110 | 37.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 101 | 108 | $22,680 | $5,788 | 25.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 82 | 82 | $9,020 | $3,659 | 40.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 55 | 55 | $7,150 | $2,617 | 36.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 29 | $8,990 | $2,323 | 25.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 32 | 42 | $5,250 | $1,349 | 25.7% |
| 58100 | Biopsy of uterine lining | Office | 2020 | 11 | 11 | $3,410 | $876.14 | 25.7% |
| 87210 | Smear for infectious agents | Office | 2020 | 16 | 16 | $304.00 | $92.52 | 30.4% |
About Dr. Jon Bellantoni, M.D
Dr. Jon Bellantoni, M.D is a Specialist healthcare provider based in Havre De Grace, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639161169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Bellantoni, M.D has received a total of $3,629 in payments from pharmaceutical and medical device companies, with $438.63 received in 2024. These payments were reported across 186 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($3,450).
As a Medicare-enrolled provider, Bellantoni has provided services to 868 Medicare beneficiaries, totaling 943 services with total Medicare billing of $55,848. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Obstetrics & Gynecology
- Location Havre De Grace, MD
- Active Since 08/19/2005
- Last Updated 10/10/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1639161169
Products in Payments
- Kyleena (Drug) $298.36
- NEXPLANON (Drug) $251.09
- LO LOESTRIN FE (Drug) $196.32
- ORILISSA (Drug) $131.07
- Veozah (Drug) $129.34
- Paragard (Device) $124.04
- LILETTA (Drug) $120.37
- MYFEMBREE (Drug) $118.60
- Lupron (Drug) $113.15
- Orilissa (Drug) $106.20
- Osphena (Drug) $101.15
- Endosee (Device) $97.40
- ORIAHNN (Drug) $87.96
- ANNOVERA (Drug) $86.86
- Leva Pelvic Floor Trainer (Device) $79.46
- INJECTAFER (Drug) $76.66
- Paragard T 380A (Drug) $61.88
- NUVARING (Drug) $58.80
- SLYND (Drug) $55.86
- HARMONIC Product Family (Device) $50.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.